Janux Therapeutics (JANX) Stock
Janux Therapeutics (JANX) closed at $11.37 on Nov 13, 2026; its Tenet Score is 74 of 100 against 407 Healthcare peers.
25 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $11.37
- Nov 13, 2026
- Market cap
- $695.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 11.15 – 35.34
- low → high
- Tenet Score
- 74/100
- Solid · 407 Healthcare peers
Industry: Drugs · see every company filed here →
Janux Therapeutics Inc scores 74/100. Solid. Strongest on value and financial health, quality is the soft spot versus 407 Healthcare peers. Insufficient inputs: Tenet 74 is built from 3 of 4 pillars, from 40% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=407Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ~ Reversal Evidence
13F flows & insider trades land here.
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in p…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Ardelyx IncARDX | 47 | $776.7M |
| Kura Oncology IncKURA | 31 | $713.9M |
| DBV TechnologiesDBVT | 32 | $692.6M |
| Universe Pharmaceuticals INCUPC | 64 | $688.4M |
| Cullinan Therapeutics IncCGEM | 54 | $667.4M |
| Olema Oncology Inc.OLMA | 55 | $662.3M |
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
Common questions
What sector and industry is Janux Therapeutics in?
Janux Therapeutics is in the Healthcare sector and the Drugs industry.
What is Janux Therapeutics' Tenet Score?
Janux Therapeutics' Tenet Score is 74 out of 100, ranked against 407 Healthcare peers as of Nov 15, 2026.




